ey will also provide you with logos or labels that you can place on your CDs to deter unauthorised copying.
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
i>Band agreements
If you write music as a band, you need to plan for the day when you will be earning royalties f
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
rom your songs, and be clear what will happen if a member of the band leaves or if the band splits up.
The best w
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
y to deal with this is to all agree what is fair, and then put this in writing as a formal agreement which you all sig
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
n. This way there is little chance of any comeback if the band splits for less than amicable reasons.
A simple se
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
ts’ should provide you with a number of sites offering advice and example contracts that you can use.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products